# A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas

> **NCT00890786** · EARLY_PHASE1 · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 27 (actual)

## Conditions studied

- Newly Diagnosed High-Grade Gliomas
- Diffuse Intrinsic Pontine Glioma

## Interventions

- **DRUG:** Temozolomide
- **DRUG:** Bevacizumab
- **DRUG:** Irinotecan

## Key facts

- **NCT ID:** NCT00890786
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2014-10
- **Final completion:** 2017-12
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2018-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00890786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00890786, "A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00890786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*